Your browser doesn't support javascript.
loading
Polysaccharides-based multiparticulated interpolyelectrolyte complexes for controlled benznidazole release.
García, Mónica C; Manzo, Rubén H; Jimenez-Kairuz, Alvaro.
Afiliación
  • García MC; Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina; Unidad de Investigación y Desarrollo en Tecnología Farmacéutica - UNITEFA (CONICET-UNC), Argentina. Electronic address: mgarcia@fcq.unc.edu.ar.
  • Manzo RH; Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina; Unidad de Investigación y Desarrollo en Tecnología Farmacéutica - UNITEFA (CONICET-UNC), Argentina. Electronic address: rubmanzo@fcq.unc.edu.ar.
  • Jimenez-Kairuz A; Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina; Unidad de Investigación y Desarrollo en Tecnología Farmacéutica - UNITEFA (CONICET-UNC), Argentina. Electronic address: alvaro@fcq.unc.edu.ar.
Int J Pharm ; 545(1-2): 366-377, 2018 Jul 10.
Article en En | MEDLINE | ID: mdl-29747000
ABSTRACT
Polysaccharides-based delivery systems and interpolyelectrolyte complexes (IPECs) are interesting alternatives to control the release of drugs, thereby improving therapies. Benznidazole (BZ) is the selected drug for Chagas disease pharmacotherapy. However, its side effects limit its efficacy and safety. We developed novel multiparticulated BZ-loaded IPECs based on chitosan and alginic acid, and investigated their physicochemical and pharmacotechnical properties. IPECs were obtained using the casting solvent method, followed by wet granulation. They presented ionic interaction between the biopolymers, revealed that free BZ was uniformly distributed and showed adequate flow properties for hard gelatin-capsule formulation. The multiparticles exhibited mucoadhesion properties and revealed modulation of BZ release, depending on the release media, in accordance with the fluid uptake. The IPECs developed possess interesting properties that are promising for the design of novel alternatives to improve Chagas disease pharmacotherapy, which would diminish BZ's adverse effects and/or allow a reduction in the frequency of BZ administration.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tripanocidas / Portadores de Fármacos / Quitosano / Alginatos / Polielectrolitos / Nitroimidazoles Idioma: En Revista: Int J Pharm Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tripanocidas / Portadores de Fármacos / Quitosano / Alginatos / Polielectrolitos / Nitroimidazoles Idioma: En Revista: Int J Pharm Año: 2018 Tipo del documento: Article